tiprankstipranks
Trending News
More News >
Cordlife Group Limited (SG:P8A)
SGX:P8A

Cordlife Group (P8A) Price & Analysis

Compare
3 Followers

P8A Stock Chart & Stats

S$0.13
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.13
S$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Revenue GrowthSustained ~17% TTM revenue growth demonstrates expanding market adoption of cord banking services across Asia. Over a 2–6 month horizon this growth supports higher lifetime customer value from annual storage fees, helps absorb fixed costs, and underpins scaling of processing capacity.
Low Leverage / Balance Sheet StrengthExtremely low leverage gives the company financial flexibility to invest in capacity, marketing, or regulatory compliance without urgent refinancing. Over months this reduces solvency risk, preserves optionality for partnerships or acquisitions, and cushions cash flow variability.
Recurring Revenue ModelThe business combines upfront collection fees with recurring annual storage revenues, creating a predictable, high-retention revenue stream. Coupled with a reported ~56% gross margin, this model supports durable unit economics and revenue visibility over multiple years.
Bears Say
Poor ProfitabilityDeep negative EBIT and net margins indicate core operating losses despite revenue growth. Persisting at current levels, these margins will erode equity, limit reinvestment capacity, and require substantial cost reductions or higher-margin service mix to achieve sustainable profitability over the medium term.
Weak Cash GenerationNegative operating cash flow and declining free cash flow growth show the business is consuming cash despite top-line gains. Over months this constrains capital allocation, may force external financing, and limits the firm's ability to fund expansion, quality controls, or strategic partnerships.
Negative Return On EquityA negative ROE signals the company currently destroys shareholder value, reflecting weak profitability relative to equity. Over a 2–6 month horizon this undermines capital-raising ability, investor confidence, and suggests operational or strategic changes are needed to improve capital efficiency.

Cordlife Group News

P8A FAQ

What was Cordlife Group Limited’s price range in the past 12 months?
Cordlife Group Limited lowest share price was S$0.12 and its highest was S$0.33 in the past 12 months.
    What is Cordlife Group Limited’s market cap?
    Cordlife Group Limited’s market cap is S$36.76M.
      When is Cordlife Group Limited’s upcoming earnings report date?
      Cordlife Group Limited’s upcoming earnings report date is Feb 26, 2026 which is tomorrow.
        How were Cordlife Group Limited’s earnings last quarter?
        Cordlife Group Limited released its earnings results on Nov 14, 2025. The company reported -S$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.01.
          Is Cordlife Group Limited overvalued?
          According to Wall Street analysts Cordlife Group Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Cordlife Group Limited pay dividends?
            Cordlife Group Limited does not currently pay dividends.
            What is Cordlife Group Limited’s EPS estimate?
            Cordlife Group Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Cordlife Group Limited have?
            Cordlife Group Limited has 267,525,360 shares outstanding.
              What happened to Cordlife Group Limited’s price movement after its last earnings report?
              Cordlife Group Limited reported an EPS of -S$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5%.
                Which hedge fund is a major shareholder of Cordlife Group Limited?
                Currently, no hedge funds are holding shares in SG:P8A
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Cordlife Group Limited

                  Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services. The company also provides corneal lenticule banking, gut microbiome banking, and lifestyle genetic screening services for adults. In addition, it offers Moms Up, a mobile application that offers parenting resources, as well as sprouts for health, wellness, and lifestyle needs. Further, the company provides medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services. Cordlife Group Limited was incorporated in 2001 and is based in Singapore.

                  Cordlife Group (P8A) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  HC Surgical Specialists Ltd
                  Hyphens Pharma International Ltd.
                  Medtecs International Corporation Ltd.
                  OUE Lippo Healthcare Limited

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks